ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,360Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1479

$365K Total Retail Price of All Prescriptions

Rank: 111 out of 1479

396 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 8,916 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
RANITIDINE HCL 585 418 1 4
SIMVASTATIN 458 357 2 1
ENALAPRIL MALEATE 398 275 3 3
METFORMIN HCL 321 260 4 2
LEVOTHYROXINE SODIUM 289 250 5 9
OMEPRAZOLE 274 187 6 7
GABAPENTIN 267 209 7 5
ATENOLOL 259 217 8 11
AMLODIPINE BESYLATE 255 211 9 6
HYDROCHLOROTHIAZIDE 227 196 10 10
LOSARTAN-HYDROCHLOROTHIAZIDE 201 125 11 14
METOPROLOL TARTRATE 184 171 12 17
LOSARTAN POTASSIUM 183 158 13 8
NAMENDA 180 180 14 69
PRAVASTATIN SODIUM 177 125 15 27
TRAMADOL HCL 172 107 16 20
GEMFIBROZIL 161 72 17 49
ZOLPIDEM TARTRATE 155 98 18 23
FUROSEMIDE 153 127 19 15
DONEPEZIL HCL 141 141 20 45
CLOPIDOGREL 138 120 21 46
GLIPIZIDE 137 98 22 13
SERTRALINE HCL 131 111 23 38
SYNTHROID 126 107 24 12
INSULIN SYRINGE 121 94 25 30
MEGESTROL ACETATE 113 108 R 26 109
NAPROXEN 113 104 26 57
CARVEDILOL 110 104 28 32
TRAMADOL HCL-ACETAMINOPHEN 109 69 29 18
CLOTRIMAZOLE-BETAMETHASONE 109 96 29 39
HUMULIN 70-30 105 69 31 43
LOVASTATIN 102 76 32 59
FENOFIBRATE 92 85 33 37
ISOSORBIDE DINITRATE 80 74 34 82
CIPROFLOXACIN HCL 79 71 35 26
PENTOXIFYLLINE 79 59 35 40
AZITHROMYCIN 71 49 37 25
PLAVIX 70 61 38 52
FLUTICASONE PROPIONATE 70 41 38 64
PANTOPRAZOLE SODIUM 67 51 40 48
CILOSTAZOL 66 54 41 65
GLIMEPIRIDE 64 64 42 21
WARFARIN SODIUM 60 60 43 83
DIOVAN 60 58 43 85
CLONIDINE HCL 59 47 45 71
OXYCODONE-ACETAMINOPHEN 57 27 S2 46 70
KETOROLAC TROMETHAMINE 54 41 R 47 216
PHENYTOIN SODIUM EXTENDED 51 49 48 132
VERAPAMIL ER 50 28 49 34
CARBIDOPA-LEVODOPA 50 50 49 184
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.